European Union · Question · QUESTION_WRITTEN
E-9-2021-003919
Use of endocrine disruptors in products that come into contact with infants and young children
Introduced
18 August 2021
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
16 November 2021
Records
Official question E-9-2021-003919 from European Union at European Parliament. Dated 18 August 2021. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Use of endocrine disrupters in products for infants and toddlers
Use of endocrine disrupters in products for infants and toddlers
QUESTION_WRITTEN · EN · 30 August 2021
Use of endocrine disrupters in products for infants and toddlers
QUESTION_WRITTEN · EN · 30 August 2021
Use of endocrine disrupters in products for infants and toddlers
QUESTION_WRITTEN · EN · 30 August 2021
Answer
QUESTION_WRITTEN_ANSWER · 16 November 2021
Verwendung von endokrinen Disruptoren in Produkten, die mit Säuglingen und Kleinkindern in Kontakt kommen
QUESTION_WRITTEN · DE · 30 August 2021
Verwendung von endokrinen Disruptoren in Produkten, die mit Säuglingen und Kleinkindern in Kontakt kommen
QUESTION_WRITTEN · DE · 30 August 2021
Verwendung von endokrinen Disruptoren in Produkten, die mit Säuglingen und Kleinkindern in Kontakt kommen
QUESTION_WRITTEN · DE · 30 August 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.